Chronic Lung Disease of Prematurity

Chronic lung disease of prematurity means a baby born very early has lungs that are not fully developed and get injured after birth. The lungs do not make enough tiny air sacs (alveoli). The blood vessels in the lungs also do not grow normally. Oxygen and breathing machines—often needed to save the baby’s life—can also irritate and inflame the lungs. Over time, this mix of immaturity, inflammation, and treatment leads to long-term breathing problems. Doctors use the term bronchopulmonary dysplasia (BPD) for this condition. The modern (“new”) BPD is mainly a problem of arrested lung growth and abnormal blood vessels, different from the older form that showed more scarring from heavy ventilation and high oxygen used in the past. PMC+1

Chronic lung disease of prematurity is a long-lasting lung problem in babies born too early. The lungs are still developing at birth. They are soft and delicate. When a very premature baby needs oxygen and breathing support to stay alive, the lungs can become inflamed and swollen. This can slow down normal lung growth. Doctors usually say a baby has BPD if the baby needs extra oxygen at 36 weeks’ post-menstrual age (about 4–8 weeks after the original due date for very early births). BPD can range from mild to severe. Many babies get better over time as the lungs grow. Some need oxygen or breathing support for months. Good nutrition, gentle ventilation, and prevention of infection are key goals of care.

Doctors grade how severe BPD is by the baby’s need for oxygen or breathing support around 36 weeks post-menstrual age (PMA). A widely used system (Jensen 2019) classifies severity based on how much respiratory support a baby needs at that time: low-flow oxygen, high-flow/non-invasive support, or invasive ventilation. This approach better matches the way we care for preterm babies today and predicts later health outcomes. PubMed+2PMC+2

Other names

• Bronchopulmonary dysplasia (BPD)

• Chronic lung disease of prematurity (CLD of prematurity, CLD)
  These names mean the same condition in everyday practice. UWA Research Repository

Types

1. “Old” BPD (seen decades ago): more airway damage and scarring due to high oxygen and aggressive ventilation. atsjournals.org

2. “New” BPD (seen today): lungs stop developing normally; fewer, larger alveoli; abnormal lung blood vessels; less scarring. NCBI

3. Severity grades at ~36 weeks PMA (Jensen 2019): grade 1 (low-flow oxygen ≤2 L/min), grade 2 (more than 2 L/min or non-invasive support), grade 3 (invasive ventilation). Some newer proposals also identify babies who die before 36 weeks due to lung disease as the most severe category. PMC+2Frontiers+2

4. Phenotypes (how it looks in different babies): some babies have more airway reactivity, some have more problems with the lung blood vessels and pulmonary hypertension (PH), and some have more low lung volumes and poor growth. orca.cardiff.ac.uk

Causes and risk factors

1. Being born very early (prematurity). The earlier the birth, the more immature the lungs and the higher the risk. PMC

2. Very low birth weight. Tiny babies have fewer developed alveoli and fragile lungs. PMC

3. Oxygen exposure. Oxygen helps survival but in high amounts or for long periods can injure tissue through oxidative stress. PMC+1

4. Mechanical ventilation. Positive pressure can over-stretch and inflame the lungs (ventilator-induced lung injury). PMC

5. Respiratory distress syndrome (surfactant deficiency). Increases need for oxygen/ventilation and adds strain to immature lungs. PMC

6. Infection before birth (chorioamnionitis). Inflammation starts early and disrupts lung growth. PMC

7. Infection after birth (sepsis, pneumonia). Adds more inflammation and injury. Spandidos Publications

8. Patent ductus arteriosus (PDA). Extra blood flow to the lungs worsens lung edema and injury. PMC

9. Poor growth in the womb and after birth. Nutrition and growth are key for lung development. PMC

10. Fluid overload and edema. Extra lung water makes breathing work harder and increases injury risk. dovepress.com

11. Acid reflux and aspiration. Milk/acid entering the lungs irritates airways. tandfonline.com

12. Genetic susceptibility. Some babies are more sensitive to injury and inflammation. PMC

13. Inadequate antioxidants. Preterm infants have low defenses against oxygen radicals. sciencedirect.com

14. Blood transfusions (possible association). Some studies link frequent transfusions with BPD risk. nejm.org

15. High tidal volumes or high pressures during resuscitation. Early over-distension can start injury. PMC

16. Frequent infections in the NICU. Repeated inflammation slows healing. Spandidos Publications

17. Lack of vitamin A. Vitamin A is important for lung growth; low levels may increase risk. cochrane.org+1

18. Oxidative stress from illness (for example, sepsis). Adds to oxygen-related injury. PMC

19. Airway reactivity and bronchospasm. Some babies have sensitive airways that narrow easily. tandfonline.com

20. Abnormal lung blood vessel development. Leads to pulmonary hypertension, which worsens outcomes. PMC

Common symptoms and signs

1. Fast breathing (tachypnea). Baby breathes many times per minute. tandfonline.com

2. Working hard to breathe. You may see chest pulling in (retractions), nasal flaring, or grunting. tandfonline.com

3. Need for oxygen for weeks. The baby cannot keep a safe oxygen level without extra oxygen. PubMed

4. Wheezing or noisy breathing. Airways are irritated and narrow easily. tandfonline.com

5. Cough or frequent congestion. tandfonline.com

6. Stops in breathing (apnea) or pauses, especially early on. tandfonline.com

7. Poor feeding and slow weight gain. Breathing takes energy; growth can lag. tandfonline.com

8. Pale or bluish skin when off oxygen. Oxygen level falls quickly. tandfonline.com

9. Frequent infections of the lungs (bronchiolitis/pneumonia). tandfonline.com

10. Trouble coming off the ventilator or CPAP. Needs support longer than peers. PubMed

11. Swelling in legs or belly if pulmonary hypertension/heart strain develops. PMC

12. Sweating with feeds from breathing effort or heart strain. tandfonline.com

13. Irritability and poor sleep. Work of breathing disturbs rest. tandfonline.com

14. Frequent hospital readmissions for breathing problems in the first years. tandfonline.com

15. Need for medications like diuretics or inhaled drugs to ease symptoms. dovepress.com

Diagnostic tests

A) Physical examination (at the bedside)

1. Observation of breathing effort. The care team watches for fast breathing, chest retractions, nasal flaring, and grunting. These show increased work of breathing because the lungs are stiff or the airways are narrow. tandfonline.com

2. Auscultation (listening to the chest). The stethoscope may pick up crackles, wheezes, or reduced breath sounds. This helps judge airway narrowing, secretions, or areas with poor airflow. tandfonline.com

3. Growth and nutrition check. Weight, length, and head size are tracked. Slow growth warns that breathing effort is high or feeding is difficult. tandfonline.com

4. Color check (skin, lips). Bluish color (cyanosis) may signal low oxygen. tandfonline.com

5. Signs of right-heart strain. Liver enlargement, swelling, or a loud second heart sound can suggest pulmonary hypertension and need for heart testing. PMC

B) Manual or functional tests (simple maneuvers or follow-up function tests)

6. Pulse oximetry spot checks with and without oxygen. A probe on the skin measures oxygen saturation while caregivers gently reduce support under supervision to see how the baby maintains levels. This helps plan safe oxygen weaning. publications.ersnet.org

7. Room-air challenge (physiologic test). Brief, careful testing in a controlled setting assesses whether the baby can stay in safe oxygen ranges without supplemental oxygen; used in some units to define readiness for discharge and aligns with “physiologic” BPD definitions. UWA Research Repository

8. Bronchodilator trial (older infants/children). In clinic, a supervised trial can show if airway reactivity contributes to symptoms. A change in symptoms or lung function suggests a reversible component. tandfonline.com

9. Infant pulmonary function testing (specialized centers). Gentle techniques measure lung volumes and flows to characterize restriction, obstruction, and air-trapping in BPD survivors. orca.cardiff.ac.uk

10. Six-minute walk test (in older children). Measures endurance and oxygen needs during activity; helps follow long-term impact. orca.cardiff.ac.uk

C) Laboratory and pathological tests

11. Blood gases (arterial/venous/capillary). Show oxygen and carbon dioxide levels and acidity. High CO₂ or low O₂ signals poor gas exchange. tandfonline.com

12. Inflammation and infection labs (CBC, CRP). Help detect infections that can worsen BPD symptoms. Spandidos Publications

13. Electrolytes and kidney function. Important when using diuretics because these drugs can change salt and fluid balance. dovepress.com

14. Vitamin A level (selected cases). Low vitamin A may be present in very preterm infants and relates to lung development. cochrane.org

15. Respiratory pathogen testing (when ill). Viral panels or cultures find triggers of sudden worsening. tandfonline.com

D) Electrodiagnostic and cardiorespiratory monitoring

16. Continuous pulse oximetry. Tracks oxygen saturation trends and alarms for drops; guides safe oxygen targets. publications.ersnet.org

17. Capnography (end-tidal CO₂). Non-invasive CO₂ monitoring can suggest ventilation problems and air-trapping. tandfonline.com

18. Polysomnography (sleep study). For older infants/children with snoring, pauses, or desaturations; quantifies oxygen dips and need for night support. tandfonline.com

E) Imaging (to look at lungs and the heart-lung circulation)

19. Chest X-ray. May show areas of over-inflation, atelectasis (collapse), and a “bubbly” or patchy look typical of BPD. Used to track lines/tubes and acute changes. tandfonline.com

20. Echocardiography (heart ultrasound). Screens for pulmonary hypertension, a serious complication of BPD, and estimates pressure in the lung vessels; should be considered in babies with significant BPD or poor progress. PMC+1

Non-pharmacological treatments (therapies and others)

1. Gentle ventilation strategies (lung-protective breathing support)
   Description: Babies with BPD often need help to breathe, but too much pressure or too much oxygen can damage the lungs. Gentle ventilation means using the lowest pressures and volumes that still keep the chest moving and oxygen levels safe. It also means aiming for slightly higher CO₂ targets (permissive hypercapnia) when appropriate, to avoid over-ventilation. Care teams adjust settings often, based on blood gases and oxygen saturation. Purpose: Reduce new lung injury while giving enough support to grow and heal. Mechanism: Lower tidal volumes and careful pressures reduce stretch injury to small air sacs (volutrauma and barotrauma). Careful oxygen targets reduce oxygen toxicity. Together, this lowers inflammation in the airways and alveoli.

2. CPAP (continuous positive airway pressure)
   Description: CPAP uses soft prongs or a mask to give a gentle, steady pressure while the baby breathes on their own. It helps keep the air sacs open between breaths. Purpose: Prevent collapse of tiny air sacs, reduce work of breathing, and limit the need for invasive ventilation. Mechanism: Constant end-expiratory pressure raises functional residual capacity, improves oxygen exchange, and decreases atelectrauma from repeated opening and closing of alveoli.

3. High-flow nasal cannula (HFNC)
   Description: HFNC delivers warmed, humidified oxygen-air through small nasal tips at higher flow rates than standard cannula. Purpose: Provide mild positive pressure and stable oxygen delivery without a tight mask. Mechanism: The high flow washes out CO₂ in the upper airway, reduces inspiratory resistance, and may create a small continuous pressure that helps keep alveoli open.

4. Targeted oxygen therapy
   Description: Nurses and doctors adjust oxygen to keep saturation within a safe range that prevents both low oxygen (hypoxia) and high oxygen (hyperoxia). Purpose: Protect the brain, heart, and other organs while minimizing oxygen toxicity and retinopathy risk. Mechanism: Tight saturation targets limit free-radical damage from excess oxygen and also prevent harm from low oxygen.

5. Early, optimized nutrition (high-calorie feeds)
   Description: Babies with BPD burn more calories due to labored breathing. They need enough protein, fat, vitamins, and minerals for lung growth. Breast milk is preferred, often fortified to meet higher needs. Purpose: Support lung tissue repair, immune function, and overall growth. Mechanism: Adequate protein supports alveolar and airway structural proteins; calories prevent catabolism; micronutrients (A, D, calcium, phosphorus) support lung and bone development.

6. Careful fluid management
   Description: Excess body water can worsen lung swelling and fluid in the air spaces. Teams watch daily fluid intake, urine output, and weight. Purpose: Reduce pulmonary edema and improve gas exchange. Mechanism: Maintaining euvolemia lowers interstitial lung water and airway narrowing, which improves oxygenation and reduces ventilator needs.

7. Infection prevention bundle
   Description: Strict hand hygiene, sterile suctioning, early detection of sepsis, and appropriate isolation help prevent infections. Vaccinations and household infection control continue after discharge. Purpose: Prevent new lung insults that can worsen BPD. Mechanism: Fewer infections mean less inflammation in the lungs and less need for higher oxygen or ventilation.

8. Kangaroo care (skin-to-skin contact)
   Description: Parents hold the baby on their bare chest for long periods, as tolerated. Purpose: Improve bonding, temperature control, and breathing stability. Mechanism: Skin-to-skin reduces stress hormones, stabilizes heart and breathing rates, and may improve oxygenation and weight gain.

9. Developmental care (NICU environment optimization)
   Description: Reduce light, noise, and frequent handling; cluster care activities; support flexed, midline positioning. Purpose: Lower stress and energy use, support better sleep, and improve growth. Mechanism: Less stress reduces oxygen needs and helps the baby reserve energy for lung healing.

10. Airway clearance techniques (gentle suctioning and positioning)
    Description: Periodic gentle suctioning, prone or side positioning as ordered, and careful chest physiotherapy in selected cases. Purpose: Keep airways clear of secretions, reduce plugging, and maintain good gas exchange. Mechanism: Removing mucus improves airflow to small airways and reduces atelectasis.

11. Weaning plans for oxygen and ventilatory support
    Description: Structured step-down protocols guide how and when to lower oxygen or pressure. Purpose: Avoid both premature weaning (destabilizing) and long delays (unnecessary exposure). Mechanism: Gradual reductions allow the lungs to adapt while monitoring saturations and work of breathing.

12. Family education and discharge planning
    Description: Teach parents oxygen safety, medication schedules, feeding plans, CPR training, and when to seek help. Purpose: Enable safe home care and reduce readmissions. Mechanism: Informed caregivers detect early problems and maintain therapy adherence.

13. Growth monitoring and catch-up nutrition after discharge
    Description: Regular checks of weight, length, head size; increase calorie density as needed. Purpose: Ensure lung and brain have the nutrients they need to mature. Mechanism: Sustained growth supports alveolarization and airway development.

14. Home oxygen therapy with pulse oximetry
    Description: Some infants go home with low-flow oxygen and an oximeter. Purpose: Keep oxygen levels safe during sleep and feeds while the lungs continue to heal. Mechanism: Supplemental oxygen improves ventilation-perfusion matching and reduces pulmonary vasoconstriction.

15. Pulmonary rehabilitation principles for infants
    Description: Age-appropriate activities with physical/occupational therapists to improve endurance and feeding coordination. Purpose: Reduce breathing effort during activity and improve overall function. Mechanism: Gradual conditioning lowers oxygen consumption per task and supports neuro-respiratory coordination.

16. Reflux management (positional and feeding strategies)
    Description: Small, frequent feeds; upright positioning after feeds; consideration of thickened feeds when advised. Purpose: Reduce aspiration risk and coughing. Mechanism: Less reflux reaching the airway means less inflammation and wheeze.

17. Sleep hygiene and safe sleep with monitors as advised
    Description: Consistent sleep routine; safe sleep positions; monitor use per clinician guidance. Purpose: Improve rest and growth while maintaining safety. Mechanism: Adequate sleep lowers metabolic demand and supports healing.

18. Immunoprophylaxis against RSV and other viruses (clinic-based)
    Description: Season-based antibody shots (see drug section for nirsevimab/palivizumab) and routine vaccines. Purpose: Prevent severe viral lung infections that worsen BPD. Mechanism: Passive antibodies neutralize RSV; active vaccines prime the immune system.

19. Multidisciplinary follow-up clinic (BPD clinic)
    Description: Coordinated visits with neonatology, pulmonology, nutrition, and therapy services. Purpose: Track progress, adjust treatments, and support families. Mechanism: Team care reduces gaps and optimizes outcomes.

20. Caregiver mental-health support
    Description: Counseling and peer groups for families coping with long NICU stays and home technology. Purpose: Reduce caregiver burnout and improve adherence. Mechanism: Lower stress improves the home care environment and baby’s stability.

---

Drug treatments

Important: Doses below are typical reference ranges used in many centers; actual dosing, timing, and route must be individualized by the neonatology team. Many uses are off-label for BPD but are common in practice. FDA label information is available on accessdata.fda.gov; always rely on the treating team’s judgment.

1. Caffeine citrate
   Class: Respiratory stimulant. Typical dose: Loading 20 mg/kg caffeine citrate (10 mg/kg caffeine base), then 5–10 mg/kg once daily. Timing: Daily, usually started in NICU. Purpose: Reduce apnea and improve breathing drive. Mechanism: Adenosine receptor antagonism stimulates the respiratory center and improves diaphragm function. Side effects: Tachycardia, irritability, feeding intolerance; rare NEC risk debates; monitor levels if needed.

2. Hydrocortisone (systemic)
   Class: Glucocorticoid. Dose: Varies widely (e.g., 1–2 mg/kg/day divided q6–8h short courses). Purpose: Reduce lung inflammation and facilitate extubation in select infants when benefits outweigh risks. Mechanism: Down-regulates inflammatory cytokines and edema. Side effects: Hyperglycemia, hypertension, infection risk, GI perforation (especially with indomethacin), potential neurodevelopmental concerns; strict risk-benefit discussion required.

3. Dexamethasone (systemic; short, low-dose regimens)
   Class: Glucocorticoid. Dose: Protocolized tapers (e.g., starting 0.15 mg/kg/day then taper over days) in selected infants. Purpose: Facilitate extubation by decreasing airway edema and inflammation. Mechanism: Potent anti-inflammatory effect. Side effects: Hypertension, hyperglycemia, infection risk, potential adverse neurodevelopmental impact with high or prolonged dosing; use restrictive protocols.

4. Budesonide (inhaled, nebulized)
   Class: Inhaled corticosteroid. Dose: Commonly 0.25–0.5 mg nebulized 1–2×/day in selected infants. Purpose: Reduce airway inflammation, wheeze, and steroid exposure compared to systemic therapy. Mechanism: Local glucocorticoid effect in airways. Side effects: Oral thrush, hoarseness; systemic effects low but possible.

5. Albuterol (salbutamol) inhalation
   Class: Short-acting β2-agonist bronchodilator. Dose: Neb 0.1–0.15 mg/kg or MDI with spacer per protocol. Purpose: Relieve bronchospasm and improve airflow. Mechanism: β2 stimulation relaxes airway smooth muscle. Side effects: Tachycardia, tremor, hypokalemia; response varies—trial with monitoring is typical.

6. Ipratropium bromide inhalation
   Class: Anticholinergic bronchodilator. Dose: Neb 0.125–0.25 mg q6–8h in selected infants. Purpose: Add-on for wheezy infants with secretion burden. Mechanism: Blocks muscarinic receptors to reduce bronchoconstriction and mucus. Side effects: Dry mouth, tachycardia (rare).

7. Furosemide
   Class: Loop diuretic. Dose: 0.5–1 mg/kg IV/PO q12–24h short courses. Purpose: Reduce lung water and improve oxygenation during pulmonary edema. Mechanism: Increases urine output by blocking Na-K-2Cl transporter in loop of Henle. Side effects: Electrolyte loss (Na, K, Cl), ototoxicity (high IV doses), nephrocalcinosis; use sparingly and monitor labs.

8. Chlorothiazide ± spironolactone
   Class: Thiazide diuretic ± potassium-sparing agent. Dose: Chlorothiazide 10–20 mg/kg q12h; spironolactone 1–3 mg/kg/day. Purpose: Chronic diuretic option to manage fluid in stable infants. Mechanism: Distal tubule natriuresis; aldosterone blockade limits K loss. Side effects: Electrolyte disturbances, metabolic alkalosis, gynecomastia (spironolactone).

9. Sodium supplementation (as needed)
   Class: Electrolyte. Dose: Individualized (e.g., 2–4 mEq/kg/day) to correct losses from diuretics. Purpose: Maintain growth and blood sodium. Mechanism: Restores extracellular volume and supports growth. Side effects: Hypernatremia if excessive; must monitor.

10. Potassium supplementation (as needed)
    Class: Electrolyte. Dose: Individualized to maintain normal K⁺ with diuretics/β-agonists. Purpose: Prevent arrhythmias and muscle weakness. Mechanism: Replaces urinary or intracellular shifts. Side effects: Hyperkalemia if overdosed; ECG monitoring if IV.

11. Inhaled nitric oxide (iNO) for documented pulmonary hypertension (PH) only
    Class: Pulmonary vasodilator gas. Dose: Typically 5–20 ppm in NICU when PH is proven. Purpose: Improve oxygenation in infants with PH physiology, not routine BPD. Mechanism: Selective pulmonary vasodilation improves ventilation-perfusion. Side effects: Methemoglobinemia, rebound PH; use only for clear indications.

12. Sildenafil for BPD-associated pulmonary hypertension
    Class: PDE-5 inhibitor. Dose: NICU protocols vary (e.g., 0.5–2 mg/kg/dose PO q6–8h). Purpose: Treat PH in infants with echocardiographic evidence. Mechanism: Inhibits cGMP breakdown, relaxing pulmonary vessels. Side effects: Hypotension, flushing; careful monitoring is required.

13. Vitamin A (retinol) IM in very low birth-weight infants
    Class: Fat-soluble vitamin. Dose: Protocols such as 5000 IU IM 3×/week for 4 weeks (center-dependent). Purpose: Reduce risk of BPD in extremely preterm infants. Mechanism: Supports epithelial repair and alveolar development. Side effects: Pain at injection site, hypervitaminosis A if excessive.

14. Iron supplementation
    Class: Micronutrient. Dose: Often 2–4 mg/kg/day elemental iron when enteral feeds are established. Purpose: Prevent anemia and support growth. Mechanism: Restores iron for hemoglobin and cellular enzymes. Side effects: Dark stools, constipation.

15. Vitamin D supplementation
    Class: Micronutrient. Dose: Typical totals 400–800 IU/day, individualized. Purpose: Bone health and immune support in preterm infants. Mechanism: Improves calcium/phosphate absorption; may modulate inflammation. Side effects: Hypercalcemia if excessive.

16. Medium-chain triglyceride (MCT) oil add-on (as part of feeds)
    Class: Caloric supplement. Dose: Added per dietitian plan to raise calories. Purpose: Improve weight gain without large feed volumes. Mechanism: MCTs are easily absorbed and used for energy. Side effects: GI upset if too much.

17. Nirsevimab (RSV monoclonal antibody) for prevention
    Class: Long-acting monoclonal antibody against RSV. Dose: Single IM dose per weight at start of RSV season. Purpose: Prevent severe RSV disease and hospitalization. Mechanism: Neutralizes RSV in the airways for months. Side effects: Injection-site reactions; hypersensitivity rare.

18. Palivizumab (RSV monoclonal antibody) alternative
    Class: Monoclonal antibody. Dose: Monthly IM injections during RSV season for eligible high-risk infants. Purpose: Reduce RSV hospitalization risk. Mechanism: RSV F-protein binding neutralizes virus. Side effects: Injection-site pain, rare allergy.

19. Proton pump inhibitor or H₂ blocker (selected cases of severe reflux/aspiration)
    Class: Acid suppression. Dose: Center-specific pediatric dosing. Purpose: Reduce acid burden in reflux that worsens lung symptoms. Mechanism: Less acid may reduce airway irritation if aspiration occurs. Side effects: Infection risk (e.g., pneumonia), altered microbiome—use sparingly.

20. Azithromycin (select centers, research-informed practice)
    Class: Macrolide antibiotic/anti-inflammatory. Dose: Protocolized courses in trials. Purpose: Target Ureaplasma or reduce airway inflammation in specific scenarios. Mechanism: Antimicrobial and immunomodulatory effects. Side effects: QT prolongation, GI upset; use only when clearly indicated.

---

Dietary molecular supplements

(Use only if prescribed by the care team; doses are examples that often vary by center and weight.)

1. Docosahexaenoic acid (DHA)
   Long description: DHA is a long-chain omega-3 fat important for brain and retinal development. In BPD, it may also calm lung inflammation. Dose: Neonatal dosing is individualized through fortified milk or formulas. Function: Structural membrane lipid; anti-inflammatory mediator. Mechanism: Competes with arachidonic acid pathways, creating less pro-inflammatory eicosanoids.

2. Arachidonic acid (ARA) with DHA balance
   Description: Balanced DHA/ARA supports membrane growth and surfactant composition. Dose: Through fortified human milk/special formulas. Function: Supports alveolar growth and surfactant phospholipids. Mechanism: Provides substrates for normal cell signaling and tissue repair.

3. Choline
   Description: Choline is essential for phosphatidylcholine, a key surfactant component. Dose: Provided via human milk fortifier/formula per dietitian. Function: Surfactant and cell membrane synthesis. Mechanism: Boosts lecithin production, supporting alveolar stability.

4. Vitamin A (enteral continuation after IM course when indicated)
   Description: Supports epithelial health and immune function. Dose: Dietitian-guided totals to avoid toxicity. Function: Epithelial repair. Mechanism: Retinoid signaling promotes alveolar septation.

5. Vitamin D
   Description: Supports bone and muscle function, including respiratory muscles. Dose: Often 400–800 IU/day total intake. Function: Calcium metabolism, immune modulation. Mechanism: Nuclear receptor signaling reduces inflammation and supports muscle strength.

6. Vitamin E
   Description: Antioxidant support in oxidative stress states. Dose: From fortified feeds; avoid excess. Function: Protects cell membranes from free radicals. Mechanism: Scavenges reactive oxygen species formed during oxygen therapy.

7. Protein fortification (whey hydrolysate)
   Description: Extra protein supports lung tissue repair and growth. Dose: Added via human milk fortifier. Function: Provides amino acids for alveolar and airway proteins. Mechanism: Builds structural and enzyme proteins in growing lungs.

8. Zinc
   Description: Important for growth and immunity. Dose: Supplemented when deficiency risk is high. Function: Supports epithelial integrity and immune defense. Mechanism: Cofactor for enzymes that repair tissue and fight infection.

9. Selenium
   Description: Antioxidant cofactor (glutathione peroxidase). Dose: Included in parenteral/enteral mixes per NICU standards. Function: Reduces oxidative injury. Mechanism: Improves detox of peroxides in lung tissue.

10. Carnitine (selected cases)
    Description: Helps transport fatty acids into mitochondria for energy. Dose: Only if deficiency suspected and approved by team. Function: Energy production for respiratory muscles. Mechanism: Improves beta-oxidation efficiency.

---

Drugs for immunity booster, regenerative, stem cell

There are no FDA-approved “stem cell” or regenerative drugs for BPD outside clinical trials. The items below explain current, careful practice and research boundaries.

1. Nirsevimab (passive immunity against RSV)
   Description (≈100 words): Long-acting antibody gives seasonal protection against RSV, a major trigger of severe lung illness in BPD. Dose: Single IM dose per season per weight band. Function: Passive immunity. Mechanism: Neutralizes RSV to prevent infection.

2. Palivizumab (passive immunity)
   Description: Monthly IM antibody during RSV season for eligible infants. Dose: Per weight each month in season. Function: Passive immunity. Mechanism: Binds RSV F-protein to prevent cell entry.

3. Synbiotic strategies (medical nutrition, not “drug”)
   Description: Selected centers use probiotic + prebiotic protocols. Dose: Center-specific. Function: Gut-lung axis support. Mechanism: Modulates immune responses; may lower infection risk. Use only if NICU policy supports it.

4. Erythropoietin (investigational for lung repair)
   Description: EPO is sometimes studied for protective effects beyond red cells. Dose: Research protocols only. Function: Potential tissue protection. Mechanism: Anti-apoptotic and antioxidant signaling; not standard for BPD.

5. Mesenchymal stromal cell (MSC) therapy (research only)
   Description: Experimental cell therapy in trials. Dose: Clinical-trial protocols only. Function: Regenerative signaling. Mechanism: Paracrine anti-inflammatory and pro-repair factors; not approved for routine care.

6. Inhaled corticosteroid + surfactant admixture (research)
   Description: Budesonide mixed with surfactant is under study. Dose: Trial protocols. Function: Targeted anti-inflammation. Mechanism: Delivers steroid to distal lung while using surfactant vehicle; investigational.

---

Surgeries

1. Tracheostomy
   Procedure: A small opening is made in the neck to place a breathing tube directly into the windpipe for long-term ventilation. Why: For infants who need prolonged ventilator support and cannot be safely extubated. It can improve comfort and growth at home with specialized support.

2. Patent ductus arteriosus (PDA) closure (surgical or catheter)
   Procedure: Ligation via small chest incision or catheter device closure. Why: A large PDA can flood the lungs with excess blood and worsen breathing. Closing it may improve lung status and feeding tolerance.

3. Gastrostomy tube (G-tube) placement
   Procedure: A feeding tube is placed through the abdomen into the stomach. Why: For babies who cannot take enough calories by mouth due to breathing effort or aspiration risk. It supports growth and makes home care easier.

4. Nissen fundoplication (anti-reflux surgery) with or without G-tube
   Procedure: The top of the stomach is wrapped around the lower esophagus to reduce reflux. Why: For severe reflux causing aspiration and repeated lung disease despite medical therapy.

5. Airway evaluation with bronchoscopy ± minor procedures
   Procedure: A small scope examines the airway; minor procedures (e.g., supraglottoplasty) may be done if structural problems are found. Why: To treat airway lesions (like malacia) that worsen breathing mechanics.

---

Preventions (practical points)

1. Prevent preterm birth where possible via good prenatal care.

2. Give antenatal steroids when preterm delivery is expected.

3. Use gentle ventilation at birth; avoid over-ventilation and high oxygen.

4. Early CPAP and non-invasive support when feasible.

5. Strict infection control in NICU and at home.

6. Optimize nutrition from day one; use human milk and fortifiers.

7. Careful fluid management to avoid lung edema.

8. RSV prevention (nirsevimab/palivizumab as eligible) and routine vaccines.

9. Smoke-free home and clean air; avoid indoor pollutants.

10. Early, regular follow-up in BPD or high-risk infant clinics.

---

When to see doctors urgently (for babies at home with BPD)

• Faster breathing, chest retractions, or pauses in breathing.

• Blue lips or face, or oxygen saturation lower than the plan.

• Poor feeding, vomiting, or fewer wet diapers.

• Fever, cough, or contact with sick people during RSV season.

• Unusual sleepiness, irritability, or behavior changes.

• Any equipment alarm you do not understand or cannot resolve.

• If you are worried for any reason—call your care team.

---

What to eat and what to avoid (for growing infants with BPD)

What to eat (as advised by your team):

1. Fortified breast milk or special preterm formula for higher calories.

2. Enough protein each day for growth (dietitian will guide).

3. Healthy fats, including MCT as advised, to meet calorie goals.

4. Vitamins A and D within safe limits from prescribed supplements.

5. Iron and zinc as prescribed to prevent deficiency.

What to avoid (or limit):

1. Over-diluted feeds (reduce calories).
2. Excess free water without medical advice (risk of hyponatremia).
3. Smoke exposure and indoor air pollution (worsen lungs).
4. Unapproved herbal products or over-the-counter meds.
5. Contact with sick visitors during respiratory virus seasons.

---

Frequently asked questions

1. Is BPD the same as “chronic lung disease”?
   Yes. In premature babies, “BPD” and “chronic lung disease of prematurity” are used for the same condition.

2. Do most babies get better?
   Many improve over months as lungs grow, though some need oxygen longer.

3. Why did my baby get BPD?
   Prematurity is the main reason. Immature lungs plus needed support can trigger inflammation.

4. Is oxygen harmful?
   Oxygen saves lives, but too much can injure lungs and eyes. Teams target safe ranges.

5. Will my baby come home on oxygen?
   Sometimes yes. Home oxygen helps growth and reduces hospital time.

6. Can my baby get infections easily?
   Preterm babies have higher risk. Hand hygiene, vaccines, and RSV antibodies help.

7. Will my child wheeze later?
   Some children wheeze in early years. Many improve as lungs grow.

8. Does nutrition really matter?
   Yes. Extra calories and protein support lung repair and brain growth.

9. Are steroids safe?
   They can help some infants. Doctors use the lowest effective dose and shortest time.

10. Why diuretics?
    They remove extra fluid that can clog tiny air spaces and worsen breathing.

11. Is breastfeeding still best?
    Yes, when possible. Human milk lowers infection risk and can be fortified.

12. Can we travel?
    Ask your team. Make a plan for oxygen, supplies, and emergency care.

13. Are air purifiers helpful?
    A clean, smoke-free home helps. Avoid strong fumes and dust.

14. What about vaccines?
    Follow the schedule. Ask about RSV prevention before each season.

15. How long will follow-up last?
    Usually through the first 2–3 years, sometimes longer if needed.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 03, 2025.